Oct 22 incident involved a ransomware attack: Dr. Reddy’s

October 28, 2020 03:12 pm | Updated 04:49 pm IST - HYDERABAD

HYDERABAD (AP) --08-01-2008 -- FOR : FILES / ARCHIVES --Dr. REDDY's LABS --A view of the Dr. Reddy's Lab facility near Hyderabad .  ---PHOTO : P_V_SIVAKUMAR

HYDERABAD (AP) --08-01-2008 -- FOR : FILES / ARCHIVES --Dr. REDDY's LABS --A view of the Dr. Reddy's Lab facility near Hyderabad . ---PHOTO : P_V_SIVAKUMAR

Dr. Reddy’s Laboratories on Wednesday said the cyber attack it had detected on last week involved a ransomware attack.

“We experienced an information security incident and consequently isolated the impacted IT services. This incident involved a ransom-ware attack,” the pharma major said in an update on the cyber attack about which it had intimated the stock exchange on October 22.

Also read | What is Ransomware?

Following the incident, the company said it had engaged leading outside cybersecurity experts and launched a comprehensive containment and remediation effort as well as investigation to address the incident.

“As of date, our investigation has not ascertained if any data breaches in the incident pertain to personally identifiable information stored in the company's systems. Recovery and restoration of all applications and data is underway. All critical operations are being enabled in a controlled manner, Dr. Reddy’s said.

In the wake of the attack, the company had temporarily shut down some of its production facilities. It had said all data center services have been isolated to take required preventive actions after detection of a cyber attack. Sources had said as a precautionary measure the company temporarily shut down some of the production facilities.

The attack had come close on the heels Dr. Reddy’s receiving Drugs Controller General of India (DCGI) approval to conduct Phase 2/3 human clinical trial for Sputnik V vaccine, developed by Russia, in the country.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.